Related Experiment Videos
Transhepatic PermCath for hemodialysis
1Kraftsow Division of Nephrology, Albert Einstein Medical Center, Philadelphia, PA 19141.
Summary
Transhepatic hemodialysis access provides a viable solution for patients with end-stage lupus nephritis when other options fail. This approach offers a reliable vascular access for long-term dialysis therapy.
Area of Science:
- Nephrology
- Vascular Surgery
- Dialysis Access
Background:
- Reliable vascular access is crucial for hemodialysis, yet its establishment and maintenance pose significant challenges.
- Patients with end-stage lupus nephritis often have limited vascular access options, with peritoneal dialysis sometimes being unsuccessful.
Observation:
- A patient with end-stage lupus nephritis, who failed peritoneal dialysis and had no other vascular access alternatives, underwent a transhepatic catheter insertion.
- The vascular access device was replaced once due to poor blood flow and reinserted once due to infection.
Findings:
- The transhepatic approach for vascular access insertion resulted in no bleeding or thrombotic complications.
- The patient successfully received adequate dialytic therapy for over one year using this transhepatic vascular access.
Implications:
- Transhepatic catheterization represents a potentially effective alternative vascular access method for hemodialysis patients with complex conditions.
- This technique may improve long-term dialysis outcomes for patients facing challenges with conventional access methods.